Jove
Visualize
Contact Us

Related Concept Videos

Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bronchoalveolar lavage to evaluate new pulmonary infiltrates in allogeneic hematopoietic stem cell transplant recipients: impact on antimicrobial optimization.

Infection prevention in practice·2021
Same author

Treatment of acute fibrinous organizing pneumonia following hematopoietic cell transplantation with etanercept.

Bone marrow transplantation·2016
Same author

Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients.

Bone marrow transplantation·2012
Same author

Improving stem cell mobilization strategies: future directions.

Bone marrow transplantation·2009
Same author

PEPCK mRNA localization in proximal tubule and gene regulation during metabolic acidosis.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2002
Same author

Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2001
Same journal

Intrapartum and 30-Day Postpartum Complications in Patients With Antenatal COVID-19 Infection: A Retrospective Cohort Study.

Infectious diseases in obstetrics and gynecology·2024
Same journal

CER818: A Highly Specific and Sensitive HPV L1 High-Risk Serological Lateral Flow Rapid Test for Early Detection of Cervical Cancer and Its Precursor Lesions.

Infectious diseases in obstetrics and gynecology·2024
Same journal

Determinants of Cervical Cancer Screening among Female Health Professionals in Harar Town, Eastern Ethiopia: A Cross-Sectional Study.

Infectious diseases in obstetrics and gynecology·2024
Same journal

Seroinfection of Antibodies to <i>Toxoplasma gondii</i>, Parvovirus B19, <i>Treponema pallidum</i>, and HIV in a Pregnant Attending a Medical Center in Northern Peru.

Infectious diseases in obstetrics and gynecology·2024
Same journal

Seroprevalence of <i>Toxocara</i> spp. in Pregnant Women: A Systematic Review and Meta-Analysis.

Infectious diseases in obstetrics and gynecology·2024
Same journal

Risk Factors Associated with Congenital Syphilis, Georgia, 2008-2015.

Infectious diseases in obstetrics and gynecology·2023
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 5, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

Azithromycin (zithromax).

J M McCarty1

  • 1Hilltop Research Centers 6079 N. Fresno #101, Fresno, CA 93710, USA.

Infectious Diseases in Obstetrics and Gynecology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Azithromycin, an azalide antibiotic, offers rapid tissue penetration and prolonged half-lives. It is effective for Chlamydia infections and respiratory tract infections, providing cost-effective treatment options.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Related Experiment Videos

Last Updated: Jul 5, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Azithromycin is a novel azalide antibiotic.
  • It exhibits unique pharmacokinetic properties, including rapid tissue penetration and extended half-lives.
  • It possesses broad-spectrum activity against Gram-positive and Gram-negative organisms.

Purpose of the Study:

  • To review the clinical efficacy and pharmacokinetic profile of azithromycin.
  • To highlight its utility in treating specific infections like chlamydial urethritis/cervicitis and community-acquired infections.
  • To emphasize its advantages in patient compliance and cost-effectiveness.

Main Methods:

  • Review of existing clinical data and pharmacokinetic studies on azithromycin.
  • Analysis of treatment outcomes for various infections.
  • Comparison with other macrolide antibiotics.

Main Results:

  • Azithromycin demonstrates excellent penetration into intracellular and interstitial tissues.
  • A single 1g dose is effective for Chlamydia trachomatis infections.
  • A 5-day regimen is effective for respiratory tract and skin infections.
  • Prolonged serum and tissue half-lives facilitate shorter treatment durations.

Conclusions:

  • Azithromycin offers a favorable pharmacokinetic profile and broad-spectrum activity.
  • It provides effective and well-tolerated treatment options for STIs and common infections.
  • Short-duration, high-compliance, and cost-effective regimens can improve patient outcomes.